Journal article
Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study
DA Sacks, DR Coustan, DR Hadden, M Hod, M Maresh, JJN Oats, C Deerochanawong, B Persson, AR Dyer, ER Trimble, BE Metzger, LP Lowe
Diabetes Care | Published : 2012
DOI: 10.2337/dc11-1641
Abstract
OBJECTIVE - To report frequencies of gestational diabetes mellitus (GDM) among the 15 centers that participated in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study using the new International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria. RESEARCH DESIGN AND METHODS - All participants underwent a 75-g oral glucose tolerance test between 24 and 32 weeks' gestation. GDM was retrospectively classified using the IADPSG criteria (one or more fasting, 1-h, or 2-h plasma glucose concentrations equal to or greater than threshold values of 5.1, 10.0, or 8.5 mmol/L, respectively). RESULTS - Overall frequency of GDM was 17.8% (range 9.3-25.5%). There was substanti..
View full abstractGrants
Awarded by National Institute of Child Health and Human Development
Funding Acknowledgements
This study was funded by grants R01-HD34242 and R01-HD34243 from the National Institute of Child Health and Human Development and the National Institute of Diabetes and Digestive and Kidney Diseases, by the National Center for Research Resources (M01-RR00048, M01-RR00080), and by the American Diabetes Association. Support has also been provided to local held centers by Diabetes UK (RD04/0002756), Kaiser Permanente Medical Center, KK Women's and Children's Hospital, Mater Mother's Hospital, and the Howard and Carol Bernick Family Foundation.Further support to local field centers has been provided by Novo Nordisk. No other potential conflicts of interest relevant to this article were reported.